Glycerin

Glycerin

SCHEMBL23629558

Cc1cc(C)c(C(=O)P(=O)(O)c2ccccc2)c(C)c1.OCC(O)CO

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
ALDH1A1 P00352 1/20 0.37
CFTR P13569 1/20 0.37
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.33
CYP1A2 P05177 1/20 0.33
ANPEP P15144 1/20 0.33
ERAP2 Q6P179 1/20 0.33
ERAP1 Q9NZ08 1/20 0.33
POLB P06746 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL117062 0.89 CFTR (0.41) LMNAALDH1A1CFTRMEN1KMT2A
SCHEMBL7647274 0.87 CFTR (0.40) LMNAALDH1A1CFTRMEN1KMT2A
Lithium SCHEMBL29525491 0.87 CFTR (0.40) LMNAALDH1A1CFTRMEN1KMT2A
SCHEMBL12813050 0.87 CFTR (0.40) LMNAALDH1A1CFTRMEN1KMT2A
SCHEMBL28569551 0.87 CFTR (0.40) LMNAALDH1A1CFTRMEN1KMT2A
Methoxymethane SCHEMBL29366991 0.84 POLB (0.38) LMNAALDH1A1CFTRMEN1KMT2A
Hypophosphorous Acid SCHEMBL30987241 0.83 CFTR (0.37) LMNAALDH1A1CFTRMEN1KMT2A
SCHEMBL10630300 0.83 ALDH1A1 (0.36) LMNAALDH1A1CFTRMEN1KMT2A
SCHEMBL28390844 0.82 CFTR (0.36) LMNAALDH1A1CFTRMEN1KMT2A
SCHEMBL2197411 0.82 MEN1 (0.38) LMNAALDH1A1CFTRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023161049-A1 PHOTOINITIATORS IGM RESINS ITALIA S.R.L. (IT) 2023-08-31 WO disclosed
US-11555081-B2 Multifunctional bisacylphosphine oxide photoinitiators IGM RESINS ITALIA S.R.L. (IT) 2023-01-17 US disclosed
US-20210347919-A1 MULTIFUNCTIONAL BISACYLPHOSPHINE OXIDE PHOTOINITIATORS IGM RESINS ITALIA S.R.L. (IT) 2021-11-11 US disclosed
EP-3847179-A1 MULTIFUNCTIONAL BISACYLPHOSPHINE OXIDE PHOTOINITIATORS IGM Resins Italia S.r.l. (IT) 2021-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11555081-B2 Multifunctional bisacylphosphine oxide photoinitiators PHOSPHO1, AGPAT5, PARG LMNA 2119/4885ALDH1A1 2367/4885CFTR 4880/4885
US-20210347919-A1 MULTIFUNCTIONAL BISACYLPHOSPHINE OXIDE PHOTOINITIATORS PHOSPHO1, AGPAT5, PARG LMNA 2119/4885ALDH1A1 2367/4885CFTR 4880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.